Advanced Ophthalmic Pharma Report issue

For profit
Founded: Tel Aviv Israel (2007)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2009
NCT00666042
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

moxifloxacin (avelox) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1